Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy

Donepezil (DNP) is the first-line drug used for Alzheimer's disease (AD). However, the therapeutic response rate of patients to DNP varies from 20 to 60%. The main reason for the large differences in the clinical efficacy of DNP therapy is genetic factors, some of which affect pharmacokinetics...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jin, Wang, Xiuzhe, Wan, Lili, Fu, Jianliang, Huo, Yan, Zhao, Yuwu, Guo, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317019/
https://www.ncbi.nlm.nih.gov/pubmed/32636753
http://dx.doi.org/10.3389/fphar.2020.00934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317019/
https://www.ncbi.nlm.nih.gov/pubmed/32636753
http://dx.doi.org/10.3389/fphar.2020.00934

Ejemplares similares